Proteome-wide reanalysis identifies coverage and error-rate limits on acquired lysines in cancer

Missense mutation in cancer creates acquired lysines, residues present in tumor cells and absent from normal cells in the same patient. The class holds 295,411 sites across 20,365 genes and falls on driver hotspots more often than other substitutions (odds ratio 1.68). Yet re-searching 42 proteomic experiments with a mutation-aware database recovers the mutant peptide in 0.63% of 8,470 site-in-cell-line observations, because a new lysine is a new cleavage site and the peptide it creates runs 6 residues against 13 for the wild type. Reported error rates do not hold either. Burden-matched entrapment puts the realized false-discovery proportion at 4.70% before score filtering, against 1% reported. Measured by competitive activity-based protein profiling across four cell lines, ligandability reproduces at the site level, no compound descriptor tested predicts it, and structure predicts it poorly at AUC 0.617. Acquired lysines are structurally ordinary, so the barrier is detection rather than chemistry.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-12
DOI
https://doi.org/10.64898/2026.11.09.765507
Primary Topic
Advanced Proteomics Techniques and Applications
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Proteome-wide reanalysis identifies coverage and error-rate limits on acquired lysines in cancer

Ayan Mukherjee, Mikail E. Abbasov, Rajib Molla, Sona Tiwari et al.
bioRxiv (Cold Spring Harbor Laboratory)
Advanced Proteomics Techniques and Applications
preprint

Proteome-wide reanalysis identifies coverage and error-rate limits on acquired lysines in cancer

Ayan Mukherjee, Mikail E. Abbasov, Rajib Molla, Sona Tiwari, Md Khaled Hossain
preprint en

Abstract

Missense mutation in cancer creates acquired lysines, residues present in tumor cells and absent from normal cells in the same patient. The class holds 295,411 sites across 20,365 genes and falls on driver hotspots more often than other substitutions (odds ratio 1.68). Yet re-searching 42 proteomic experiments with a mutation-aware database recovers the mutant peptide in 0.63% of 8,470 site-in-cell-line observations, because a new lysine is a new cleavage site and the peptide it creates runs 6 residues against 13 for the wild type. Reported error rates do not hold either. Burden-matched entrapment puts the realized false-discovery proportion at 4.70% before score filtering, against 1% reported. Measured by competitive activity-based protein profiling across four cell lines, ligandability reproduces at the site level, no compound descriptor tested predicts it, and structure predicts it poorly at AUC 0.617. Acquired lysines are structurally ordinary, so the barrier is detection rather than chemistry.

bioRxiv (Cold Spring Harbor Laboratory)
University of Oklahoma Health Sciences Center (US)
Good health and well-being
Advanced Proteomics Techniques and Applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon